GT
56
-3
MCO
71
-7
CTAS
53
-3
ADM
28
3
WEC
53
5
URBN
48
-6
RSG
65
-3
TGT
45
-4
SYF
86
-6
DTE
43
5
RCL
83
-2
TROW
47
-6
NSC
53
-4
PVH
60
-4
WM
74
-5
MNST
45
-21
F
56
-3
CVS
41
-4
WYNN
36
-5
FSLR
44
-2
GT
56
-3
MCO
71
-7
CTAS
53
-3
ADM
28
3
WEC
53
5
URBN
48
-6
RSG
65
-3
TGT
45
-4
SYF
86
-6
DTE
43
5
RCL
83
-2
TROW
47
-6
NSC
53
-4
PVH
60
-4
WM
74
-5
MNST
45
-21
F
56
-3
CVS
41
-4
WYNN
36
-5
FSLR
44
-2
Financhill
Back

Vir Biotechnology Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
39

VIR
Vir Biotechnology

Last Price:
8.01
Seasonality Move:
40.05%
Buy
56

BMRN
Biomarin Pharmaceutical

Last Price:
63.43
Seasonality Move:
13.04%
Sell
39
Vir Biotechnology (VIR) is a Sell

Is Vir Biotechnology a Buy, Sell or Hold?

  • The current Vir Biotechnology [VIR] share price is $8.01. The Score for VIR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • VIR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.42. The Score for BMRN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VIR Stock Price Chart

What is Vir Biotechnology's stock price today?

  • The Vir Biotechnology share price today is $8.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIR is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

VIR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.31 Buy
Relative Strength Index (14 RSI): 43.74 Sell
Chaikin Money Flow: -957866 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.43 - 9.31) Sell
Bollinger Bands (100): (7.58 - 9.46) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.75 Sell
Relative Strength Index (14 RSI): 26.27 Sell
Chaikin Money Flow: -1448636 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.93 - 70.21) Sell
Bollinger Bands (100): (69.5 - 87.66) Sell

VIR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.29 Sell
20-day SMA: 8.53 Sell
50-day SMA: 8.01 Buy
200-day SMA: 9.21 Sell
8-day EMA: 8.88 Sell
20-day EMA: 8.66 Sell
50-day EMA: 8.37 Sell
200-day EMA: 9.51 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.04 Sell
20-day SMA: 67.52 Sell
50-day SMA: 70.73 Sell
200-day SMA: 81.7 Sell
8-day EMA: 65.78 Sell
20-day EMA: 67.26 Sell
50-day EMA: 71.26 Sell
200-day EMA: 80.23 Sell

Vir Biotechnology Earnings Growth & VIR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.10 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Vir Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):